The Prostatype Genomics share

Prostatype Genomics AB has issued shares in one series. The company’s share is as of 27 October 2020 listed on NASDAQ First North Growth Market under the ticker PROGEN and is traded with ISIN code SE0014684569.

All shares hold equal rights to the company’s assets and profits. The company’s share is denominated in SEK and has been issued in accordance with Swedish law. The shares give preferential rights to future issues unless otherwise decided. Each share entails equal rights to dividends and to any surplus in the event of liquidation.

There are no restrictions on any dividend other than those resulting from Swedish law. All shares are freely transferable. The shares are registered in electronic form in accordance with the record reservation in the Articles of association. The share register is kept by Euroclear.

Share information

Trading Summary

Trading volume per month